Ittai Harel

Ittai Harel has been working in the venture capital industry since 2006, when they began as Managing General Partner at Pitango Venture Capital. In 2016, they joined the Investment Committee of MindUP - The Digital Health Incubator. In 2017, they were a Member of the Board of Directors for CLEW, as well as a Director Board of Directors for DouxMatok. In 2018, they were an Observer on the Board of Directors for Visby Medical. In 2019, they were a Director Board of Directors for TScan Therapeutics. In 2020, they were a Director Board of Directors for Homethrive, Inc. In 2021, they were a Director Board of Directors for Connie Health and ImmuneID. Finally, in 2022, they became a Director Board of Directors for Protai.

Ittai Harel received their BSc in Chemical Engineering and Biotechnology from Ben-Gurion University of the Negev in 1993. Ittai then went on to pursue an MSc in Management and Marketing from MIT Sloan School of Management, which they completed in 1995.